vs

Side-by-side financial comparison of GrowGeneration Corp. (GRWG) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

GrowGeneration Corp. is the larger business by last-quarter revenue ($37.8M vs $19.6M, roughly 1.9× STANDARD BIOTOOLS INC.). GrowGeneration Corp. runs the higher net margin — -19.6% vs -177.4%, a 157.8% gap on every dollar of revenue. On growth, GrowGeneration Corp. posted the faster year-over-year revenue change (1.0% vs -11.5%). Over the past eight quarters, GrowGeneration Corp.'s revenue compounded faster (-11.1% CAGR vs -12.2%).

GrowGeneration Corp is a leading U.S.-based specialty retailer of hydroponics and organic gardening supplies. It offers a full portfolio of products including grow lights, nutrient solutions, climate control systems and cultivation tools, serving both commercial indoor farming operators (including legal cannabis cultivators) and hobbyist home gardeners via its nationwide physical store network and e-commerce channels.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

GRWG vs LAB — Head-to-Head

Bigger by revenue
GRWG
GRWG
1.9× larger
GRWG
$37.8M
$19.6M
LAB
Growing faster (revenue YoY)
GRWG
GRWG
+12.5% gap
GRWG
1.0%
-11.5%
LAB
Higher net margin
GRWG
GRWG
157.8% more per $
GRWG
-19.6%
-177.4%
LAB
Faster 2-yr revenue CAGR
GRWG
GRWG
Annualised
GRWG
-11.1%
-12.2%
LAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
GRWG
GRWG
LAB
LAB
Revenue
$37.8M
$19.6M
Net Profit
$-7.4M
$-34.7M
Gross Margin
24.1%
48.5%
Operating Margin
-20.1%
-168.5%
Net Margin
-19.6%
-177.4%
Revenue YoY
1.0%
-11.5%
Net Profit YoY
68.2%
-28.8%
EPS (diluted)
$-0.12
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRWG
GRWG
LAB
LAB
Q4 25
$37.8M
Q3 25
$47.3M
$19.6M
Q2 25
$41.0M
$21.8M
Q1 25
$35.7M
$40.8M
Q4 24
$37.4M
Q3 24
$50.0M
$22.1M
Q2 24
$53.5M
$22.5M
Q1 24
$47.9M
$45.5M
Net Profit
GRWG
GRWG
LAB
LAB
Q4 25
$-7.4M
Q3 25
$-2.4M
$-34.7M
Q2 25
$-4.8M
$-33.5M
Q1 25
$-9.4M
$-26.0M
Q4 24
$-23.3M
Q3 24
$-11.4M
$-26.9M
Q2 24
$-5.9M
$-45.7M
Q1 24
$-8.8M
$-32.2M
Gross Margin
GRWG
GRWG
LAB
LAB
Q4 25
24.1%
Q3 25
27.2%
48.5%
Q2 25
28.3%
48.8%
Q1 25
27.2%
48.4%
Q4 24
16.4%
Q3 24
21.6%
54.9%
Q2 24
26.9%
46.1%
Q1 24
25.8%
53.1%
Operating Margin
GRWG
GRWG
LAB
LAB
Q4 25
-20.1%
Q3 25
-6.0%
-168.5%
Q2 25
-12.9%
-118.1%
Q1 25
-27.7%
-80.8%
Q4 24
-63.9%
Q3 24
-24.2%
-120.9%
Q2 24
-12.2%
-134.5%
Q1 24
-19.7%
-132.2%
Net Margin
GRWG
GRWG
LAB
LAB
Q4 25
-19.6%
Q3 25
-5.2%
-177.4%
Q2 25
-11.7%
-153.7%
Q1 25
-26.3%
-63.8%
Q4 24
-62.4%
Q3 24
-22.9%
-122.0%
Q2 24
-11.0%
-203.3%
Q1 24
-18.5%
-70.6%
EPS (diluted)
GRWG
GRWG
LAB
LAB
Q4 25
$-0.12
Q3 25
$-0.04
$-0.09
Q2 25
$-0.08
$-0.09
Q1 25
$-0.16
$-0.07
Q4 24
$-0.39
Q3 24
$-0.19
$-0.07
Q2 24
$-0.10
$-0.12
Q1 24
$-0.14
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRWG
GRWG
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$46.1M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$97.5M
$399.7M
Total Assets
$147.0M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRWG
GRWG
LAB
LAB
Q4 25
$46.1M
Q3 25
$48.3M
$129.4M
Q2 25
$48.7M
$158.6M
Q1 25
$52.6M
$150.9M
Q4 24
$56.5M
Q3 24
$55.2M
$210.6M
Q2 24
$56.0M
$269.8M
Q1 24
$61.3M
$287.1M
Total Debt
GRWG
GRWG
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
GRWG
GRWG
LAB
LAB
Q4 25
$97.5M
Q3 25
$104.7M
$399.7M
Q2 25
$106.7M
$424.5M
Q1 25
$111.2M
$454.6M
Q4 24
$120.1M
Q3 24
$143.2M
$489.3M
Q2 24
$155.8M
$510.3M
Q1 24
$165.3M
$577.3M
Total Assets
GRWG
GRWG
LAB
LAB
Q4 25
$147.0M
Q3 25
$159.6M
$539.6M
Q2 25
$160.6M
$557.0M
Q1 25
$164.2M
$579.6M
Q4 24
$174.4M
Q3 24
$199.6M
$681.5M
Q2 24
$219.2M
$708.7M
Q1 24
$230.4M
$777.7M
Debt / Equity
GRWG
GRWG
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRWG
GRWG
LAB
LAB
Operating Cash FlowLast quarter
$-2.2M
$-22.2M
Free Cash FlowOCF − Capex
$-23.1M
FCF MarginFCF / Revenue
-118.1%
Capex IntensityCapex / Revenue
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRWG
GRWG
LAB
LAB
Q4 25
$-2.2M
Q3 25
$-499.0K
$-22.2M
Q2 25
$-2.9M
$-20.7M
Q1 25
$-3.8M
$-30.3M
Q4 24
$1.1M
Q3 24
$1.2M
$-27.9M
Q2 24
$-398.0K
$-39.0M
Q1 24
$-3.6M
$-62.5M
Free Cash Flow
GRWG
GRWG
LAB
LAB
Q4 25
Q3 25
$-23.1M
Q2 25
$-22.6M
Q1 25
$-35.3M
Q4 24
Q3 24
$-30.1M
Q2 24
$-41.0M
Q1 24
$-63.3M
FCF Margin
GRWG
GRWG
LAB
LAB
Q4 25
Q3 25
-118.1%
Q2 25
-103.6%
Q1 25
-86.6%
Q4 24
Q3 24
-136.4%
Q2 24
-182.2%
Q1 24
-138.9%
Capex Intensity
GRWG
GRWG
LAB
LAB
Q4 25
Q3 25
4.5%
Q2 25
8.7%
Q1 25
12.4%
Q4 24
Q3 24
10.2%
Q2 24
8.6%
Q1 24
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRWG
GRWG

Consumables$22.3M59%
Durables$9.8M26%
Commercial Fixture Sales$5.7M15%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons